Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Fortis Sells its Singapore Surgical Hospital

Fortis Healthcare International Pte Ltd, a subsidiary of Fortis Healthcare Ltd (BSE: FORTIS), sold its Fortis Surgical Hospital in Singapore to Beijing-based Concord Medical Services Holdings Limited (NYSE: CCM). The 31-bed hospital sold for $39.8 million, or $1.28 million per bed. Concord plans to rename the facility the Singapore Concord Cancer Hospital, and to add more medical specialties, such as oncology, cardiology, respiratory, dermatology, renal medicine and more. Read More »

Back to Smaller Hospital Deals

Our annual 2015 Health Care Services Acquisition Report is getting ready to go to press, and we thought we’d share a bit of data on hospital transactions in recent years. Between 2008 and 2011, an average of 1.4 facilities were involved in each hospital deal. In 2012 and 2013, however, larger systems came into play, and the average number of facilities per transaction grew to 2.3 in 2012 and 3.4 in 2013. Despite the stronger market for hospitals last year, the average number of facilities per deal dropped to 1.8. The report will be available in early April, brimming with data on average price-per-bed, revenue-per-deal, and a look at M&A trends in nine service sectors. Reserve your copy... Read More »

Another PBM Changes Hands

Early this month we wrote about the pick-up in M&A activity around pharmacy benefits management (PBM) companies, particularly as private equity firms made exits. Last week, another PBM made M&A news, as Magellan Health (NASDAQ: MGLN) paid $55 million to acquire 4D Pharmacy Management Systems in Troy, Michigan. 4D Pharmacy has strong presence in the growing markets of Medicare, dual eligible and healthcare exchanges. Plus, Magellan expects 4D to produce approximately $400 million in revenue in 2015, pre- and post-acquisition. Read More »

Janssen Scoops Up XO1

No, XO1 is not a drug candidate, it’s the name of an asset-centric virtual biopharmaceutical company, XO1 Limited, a UK-based portfolio company of Index Ventures. Janssen Pharmaceuticals (NYSE: JNJ) paid an undisclosed price for the virtual company, which was founded solely to develop the anti-thrombin antibody ichorcumab, which basically acts as an anticoagulant but doesn’t cause bleeding, like previous blood thinners. XO1 and Index Ventures licensed the technology from Cambridge University Hospitals, where it was developed. Read More »

UPMC Acquires Local Hospice Provider

The University of Pittsburgh Medical Center (UPMC) has been busy this year, with two acquisitions and a “significant investment,” after 18 months off the M&A circuit. This month’s acquisition was Family Hospice and Palliative Care, also in Pittsburgh. The company is the state’s largest not-for-profit medical services provider for people with terminal illness. UPMC also made an undisclosed investment in Health Fidelity, a Palo Alto-based technology company with a “risk adjustment solution” that was deployed by UPMC Health Plan last year. UPMC’s previous acquisition was Jameson Health System in New Castle, Pennsylvania, announced in February. Read More »

Endo Tries to Upstage Valeant’s Bid for Salix

It’s not over until the fat check arrives. That’s the story of Salix Pharmaceuticals (NASDAQ: SLXP), which last month accepted Valeant Pharmaceuticals’ (NYSE: VRX) $10.1 billion acquisition offer. Valeant thought it had snatched victory from Shire plc (NASDAQ: SHPG) and Endo International plc (NASDAQ: ENDP), which were also readying bids for the troubled Salix. Endo apparently wasn’t daunted, and last week came back with a cash and stock bid of approximately $11.1 billion. Stay tuned. Read More »

Year’s Biggest Billion-Dollar Deals Top $64 Billion

Already in 2015, we’ve recorded 11 billion-dollar-plus deals, for a total of $64.4 billion. Thanks to the $21 billion AbbVie (NYSE: ABBV) bid for Pharmacyclics (NASDAQ: PCYC), the biotechnology sector accounted for $27.5 billion of those big deals. Pharmaceuticals, with four billion-plus transactions, still ranks first, with combined spending of $30.45 billion.  Read More »

Doc Group Acquisitions Pick Up

After a few quiet weeks with no announcements, the Physician Medical Group sector got busy. Sheridan Healthcare, a subsidiary of AmSurg Corp. (NASDAQ: AMSG), acquired Radiology Associates of Hollywood (Florida), which handles radiology services for 12 hospitals and other facilities in Broward County. US Anesthesia Partners picked up another Texas-based practice, Excel Anesthesia, P.A., which it will merge into Pinnacle Anesthesia Consultants, one of its founding partners. Then Partners HealthCare System, which was spurned by the Massachusetts Attorney General in its bid for South Shore Hospital, turned around and angered the AG once again by acquiring Harbor Medical Associates in South... Read More »